Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
FRE1 of $1.2 million and SRE1 of $2.0 million for the first quarter of 2026, resulting in Segment Income of $3.3 million1 representing a 41% increase, or $1.2 million, as compared to prior year. As...
-
Revenue of $4.3 million in Q1 2026, compared to $1.1 million in Q1 2025 on a comparable GAAP basisDelivered 21 vehicles in Q1 2026, compared to 5 vehicles in Q1 2025Announced 100-vehicle W56 purchase...
-
IRVING, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a multinational technology and services company orchestrating...
-
Revenues Decreased 15% to $24.2 Million, as Q1 2025 included Revenue of Approximately $3.5 million From Renewal of Two Delayed Contracts with the New York City Police Department Company Reaffirms FY...
-
AVITA Medical reports Q1 2026 results: $19.3M revenue, improving demand, cost discipline, and progress across its acute wound care platform.
-
Net revenues increased 21% year-over-year Net income increased 25% year-over-year to $2.3M; year-to-date net income grew 78% to $16.6M Adjusted EBITDA increased to $5.1M in Q3; year-to-date Adjusted...
-
SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the...
-
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading developer of the world’s largest resource of critical metals essential to...
-
New York, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight The oligonucleotides...
-
English Summary Crakmedia has been named one of Canada’s Top 100 Small & Medium Employers for 2026 by The Globe and Mail. This prestigious recognition high